Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

  40,287,245      
Direct Value   $126,239,827    

Indirect Value

  $40,279,714      
Total Shares   87,362,343      
Total Value   $166,519,541      


Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $34,149,711 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $4,295,610 Achieve Life Sciences Inc
 $4,514,202 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $113,479 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,060,627 ReShape Lifesciences Inc
 $831,407 Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $34,149,711 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $4,295,610 Achieve Life Sciences Inc
 $4,514,202 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $113,479 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,060,627 ReShape Lifesciences Inc
 $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    99   
    96    

     Stock price went up :

    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

Download
  Page 16 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TENX Tenax Therapeutics Inc 10% Owner   –       –       •   2020-08-24 4 B $1.47 $8,367 D/D 5,692 1,840,784 2.37 %
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-05-14 4 B $0.53 $8,417 D/D 15,758 16,742,500 3.84 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-03 4 S $0.16 $8,557 D/D (53,479) 18,808,308 0 %
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-02 4 B $0.36 $8,609 D/D 23,913 24,207,280 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-04 4 B $4.35 $8,755 D/D 2,015 17,502,415 3.84 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2019-05-24 4 B $2.19 $8,760 D/D 4,000 1,060,000 2.37 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-06 4 B $1.12 $8,960 D/D 8,000 6,936,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-04-03 4 B $2.16 $9,245 I/I 4,280 832,194 2.17 %
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-02 4 B $1.16 $9,280 D/D 8,000 6,924,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-30 4 B $4.26 $9,377 D/D 2,200 16,479,345 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-21 4 B $0.61 $9,535 D/D 15,564 15,715,564 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-05-17 4 B $5.33 $9,583 D/D 1,798 18,334,285 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-09-22 4 B $0.78 $9,641 D/D 12,300 15,979,165 3.84 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-05 4 B $0.63 $9,953 D/D 15,798 3,159,999 2.37 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-05-25 4 B $0.58 $10,116 D/D 17,575 16,761,800 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-09-01 4 B $0.73 $10,188 D/D 13,867 15,908,837 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-20 4 B $0.85 $10,208 I/I 12,000 46,412,000 2.17 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-09-26 4 B $0.80 $10,774 D/D 13,552 15,992,717 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-18 4 B $4.35 $10,866 D/D 2,500 16,448,219 3.92 -
FRTX Fresh Tracks Therapeutics... 10% Owner   –       –       •   2018-06-26 4 B $1.24 $11,322 D/D 9,103 3,051,879 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-09-20 4 B $0.76 $11,610 D/D 15,250 15,964,505 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-22 4 B $0.62 $11,895 D/D 19,301 15,734,865 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-11-24 4 B $1.20 $11,980 D/D 10,000 16,050,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-05-10 4 B $4.95 $12,395 D/D 2,504 18,306,789 3.92 -
TENX Tenax Therapeutics Inc Director   –       •       •   2020-09-08 4 B $1.46 $12,473 D/D 8,543 2,019,995 3.92 %

  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 16 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed